Articles

• Select this article
  • N E Hynes,
  • K Horsch,
  • M A Olayioye,
  • and A Badache

  The ErbB receptor tyrosine family as signal integrators.

  Endocr Relat Cancer 8 (3) 151-9, doi:10.1677/erc.0.0080151
  • Abstract
  • Full Text (PDF)
• Select this article
  • E Zwick,
  • J Bange,
  • and A Ullrich

  Receptor tyrosine kinase signalling as a target for cancer intervention strategies.

  Endocr Relat Cancer 8 (3) 161-73, doi:10.1677/erc.0.0080161
  • Abstract
  • Full Text (PDF)
• Select this article
  • R I Nicholson,
  • I R Hutcheson,
  • M E Harper,
  • J M Knowlden,
  • D Barrow,
  • R A McClelland,
  • H E Jones,
  • A E Wakeling,
  • and J M Gee

  Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.

  Endocr Relat Cancer 8 (3) 175-82, doi:10.1677/erc.0.0080175
  • Abstract
  • Full Text (PDF)
• Select this article
  • N J Bundred,
  • K Chan,
  • and N G Anderson

  Studies of epidermal growth factor receptor inhibition in breast cancer.

  Endocr Relat Cancer 8 (3) 183-9, doi:10.1677/erc.0.0080183
  • Abstract
  • Full Text (PDF)
• Select this article
  • M Dowsett

  Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer.

  Endocr Relat Cancer 8 (3) 191-5, doi:10.1677/erc.0.0080191
  • Abstract
  • Full Text (PDF)
• Select this article
  • D Sachdev and
  • D Yee

  The IGF system and breast cancer.

  Endocr Relat Cancer 8 (3) 197-209, doi:10.1677/erc.0.0080197
  • Abstract
  • Full Text (PDF)
• Select this article
  • B Spencer-Dene,
  • C Dillon,
  • V Fantl,
  • K Kerr,
  • A Petiot,
  • and C Dickson

  Fibroblast growth factor signalling in mouse mammary gland development.

  Endocr Relat Cancer 8 (3) 211-7, doi:10.1677/erc.0.0080211
  • Abstract
  • Full Text (PDF)
• Select this article
  • J F Lyons,
  • S Wilhelm,
  • B Hibner,
  • and G Bollag

  Discovery of a novel Raf kinase inhibitor.

  Endocr Relat Cancer 8 (3) 219-25, doi:10.1677/erc.0.0080219
  • Abstract
  • Full Text (PDF)
• Select this article
  • S R Johnston and
  • L R Kelland

  Farnesyl transferase inhibitors--a novel therapy for breast cancer.

  Endocr Relat Cancer 8 (3) 227-35, doi:10.1677/erc.0.0080227
  • Abstract
  • Full Text (PDF)
• Select this article
  • R C Stein

  Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment.

  Endocr Relat Cancer 8 (3) 237-48, doi:10.1677/erc.0.0080237
  • Abstract
  • Full Text (PDF)
• Select this article
  • K Yu,
  • L Toral-Barza,
  • C Discafani,
  • W G Zhang,
  • J Skotnicki,
  • P Frost,
  • and J J Gibbons

  mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.

  Endocr Relat Cancer 8 (3) 249-58, doi:10.1677/erc.0.0080249
  • Abstract
  • Full Text (PDF)
• Select this article
  • P E L√∏nning,
  • T S√∏rlie,
  • C M Perou,
  • P O Brown,
  • D Botstein,
  • and A L B√∏rresen-Dale

  Microarrays in primary breast cancer--lessons from chemotherapy studies.

  Endocr Relat Cancer 8 (3) 259-63, doi:10.1677/erc.0.0080259
  • Abstract
  • Full Text (PDF)